APGE

Apogee Therapeutics, Inc. is an innovative biotechnology company based in Waltham, Massachusetts, focused on developing advanced biologic therapies for chronic inflammatory conditions, including atopic dermatitis and chronic obstructive pulmonary disease (COPD). The company is distinguished by its robust pipeline aimed at addressing significant unmet medical needs in the field of immunology, underscoring its commitment to enhancing patient outcomes. With a strong foundation in cutting-edge science and a strategic vision, Apogee is well-positioned to make a substantial impact in the evolving biopharmaceutical landscape and drive future growth in therapeutic development.